Finance

Lists
Why is MLTX down 6.16%?
Dive Deeper
MLTX:NASDAQ
MoonLake Immunotherapeutics
$11.73
-6.16%
(-0.77) 1D
$11.73
0.00% (0.00)
After hours
Closed: Nov 16, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MLTX...
Open
$12.48
High
$12.78
Low
$11.64
Mkt. cap
998.30M
Avg. vol.
1.76M
Volume
0.00
52-wk high
$23.29
52-wk low
$9.46
EPS
-$3.66
Beta
1.14
Shares outstanding
85.11M
No. of employees
130
Open
$12.48
High
$12.78
Low
$11.64
Mkt. cap
998.30M
Avg. vol.
1.76M
Volume
0.00
52-wk high
$23.29
52-wk low
$9.46
EPS
-$3.66
Beta
1.14
Shares outstanding
85.11M
No. of employees
130
News stories
From web sources and news partners
About MoonLake Immunotherapeutics
CEO-
Employees130
Founded2020
HeadquartersZug, Zug, Switzerland
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 9 analysts giving stock ratings to MLTX in the past 3 months
Strong buy
Buy
8
Hold
1
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for MLTX in the last 3 months.
Highest
Current $11.73
$57.00 (+385.93%)
Average
$36.13 (+208.01%)
Lowest
$15.00 (+27.88%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Smith
Leerink Partners
Buy
Reiterated
$30.00
+155.8%
11/16/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$50.00
+326.3%
11/09/2026
Andreas Argyrides
Chardan Capital
Buy
Initiated
$57.00
+385.9%
11/06/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
$40.00
+241%
11/04/2026
Julian Harrison
BTIG
Buy
Maintained
$30.00
+155.8%
11/04/2026
Yun Zhong
Wedbush
Buy
Maintained
$34.00
+189.9%
11/04/2026
Brian Abrahams
RBC Capital
Hold
Maintained
$15.00
+27.9%
11/04/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
10/01/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$33.00
+181.3%
09/30/2026
Serge Belanger
Needham
Buy
Maintained
$30.00
+155.8%
08/10/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
$70.00
+496.8%
06/22/2026
Richard Law CFA
Goldman Sachs
Sell
Maintained
$12.00
+2.3%
05/11/2026
Andy Chen
Wolfe Research
Buy
Upgraded
$24.00
+104.6%
03/23/2026
Samantha Semenkow
Citi
Sell
Maintained
$6.00
-48.8%
03/20/2026
Qize Ding
Rothschild & Co Redburn
Buy
Upgraded
$40.00
+241%
03/19/2026
Alex Thompson CFA
Stifel Nicolaus
Hold
Maintained
$19.00
+62%
03/01/2026
Yatin Suneja
Guggenheim
Buy
Maintained
$20.00
+70.5%
02/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
56.01M
54.52M
50.22M
68.87M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.21M
15.51M
11.44M
10.98M
Operating expense
65.22M
70.02M
61.66M
79.85M
Total operating expenses
65.22M
70.02M
61.66M
79.85M
Operating income
-65.22M
-70.02M
-61.66M
-79.85M
Other non operating income
3.92M
3.15M
2.87M
3.80M
EBT including unusual items
-62.77M
-69.08M
-61.72M
-78.91M
EBT excluding unusual items
-62.77M
-69.08M
-61.72M
-78.91M
Income tax expense
248.00K
622.00K
90.00K
631.00K
Effective tax rate
-0.40%
-0.90%
-0.15%
-0.80%
Other operating expenses
-
-
-
-
Net income
-62.43M
-69.71M
-61.80M
-79.54M
Net profit margin
-
-
-
-
Earnings per share
-0.92
-0.98
-0.84
-0.93
Interest and investment income
-
-
-
-
Interest expense
-1.99M
-2.27M
-2.63M
-2.66M
Net interest expenses
-1.99M
-2.27M
-2.63M
-2.66M
Depreciation and amortization charges
-
-
-
-
EBITDA
-64.47M
-69.18M
-60.76M
-78.95M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps